Natera (NASDAQ:NTRA – Get Rating) had its price objective hoisted by Credit Suisse Group from $65.00 to $70.00 in a research note released on Wednesday morning, The Fly reports. A number of other equities analysts have also recently commented on the stock. UBS Group started coverage on shares of Natera in a research note on […]
Natera (NASDAQ:NTRA – Get Rating) posted its quarterly earnings results on Tuesday. The medical research company reported ($1.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.18) by ($0.05), Briefing.com reports. Natera had a negative net margin of 66.79% and a negative return on equity of 106.67%. The business had revenue […]
Natera (NASDAQ:NTRA – Get Rating) issued its earnings results on Tuesday. The medical research company reported ($1.23) EPS for the quarter, missing the consensus estimate of ($1.18) by ($0.05), Briefing.com reports. The company had revenue of $241.76 million for the quarter, compared to analysts’ expectations of $227.43 million. Natera had a negative return on equity […]
Natera (NASDAQ:NTRA – Get Rating) posted its quarterly earnings results on Tuesday. The medical research company reported ($1.23) EPS for the quarter, missing the consensus estimate of ($1.18) by ($0.05), Briefing.com reports. Natera had a negative return on equity of 106.67% and a negative net margin of 66.79%. The company had revenue of $241.76 million […]
UBS Group initiated coverage on shares of Natera (NASDAQ:NTRA – Get Rating) in a research report report published on Friday morning, The Fly reports. The firm issued a buy rating and a $76.00 target price on the medical research company’s stock. Other equities analysts have also issued reports about the stock. Piper Sandler lifted their […]